Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-207-2 | CAS number: 2156592-65-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute toxicity profile of benzene, mono-C10-13-alkyl derivatives, distillation residues, sulfonated, sodium salt (registered substance/target substance) was not determined by actual acute toxicity studies. Instead, read across substances were used to predict the acute toxicity of the registered substance.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted according to OECD Guidelines and to GLP, but not fully reported. However as this study is used in the context of a read across, Klimisch 2 is assigned.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- None provided in study report.
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 5000 mg/kg bw
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- Animals were observed for 14 days following administration of the test substance.
Bodyweights were recorded on the day of dosing and at 2, 7 and 14 days after dosing.
Necropsy of survivors performed: yes
Clinical signs were observed and bodyweights measured. - Statistics:
- No mortality occurred. Use of statistics not indicated.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000
- Remarks on result:
- other: 95% CL not indicated. LD50 is greater than 5000 mg/kg bw.
- Mortality:
- Mortality did not occur in treated animals.
- Clinical signs:
- Diarrhoea and reduced food intake were observed in one treated female on day one of dosing.
- Body weight:
- No significant change in bodyweights occurred in treated animals.
- Gross pathology:
- No treatment related effects were observed on necropsy.
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Mortality did not occur at doses of 5000 mg/kg bw, therefore, and LD50 was not determined.
- Executive summary:
In an acute oral toxicity study, groups of Sprague-Dawley rats (5/sex) were given a single oral dose of sodium 4-icosylbenzenesulfonate at doses of 0 or 5000 mg/kg bw and observed for 14 days.
No mortality occurred in this limit test, therefore an LD50 has not been determined.
This acute oral study is classified as acceptable. It satisfies the guideline requirement for an acute oral study OECD 401 in the rat.
Reference
Table 2: Number of animals dead [and with evident toxicity] [and time range within which mortality occurred]
Dose |
Mortality (# dead/total) |
Time range of deaths (hours) |
Number with evident toxicity (#/total) |
||||
Male |
Female |
Combined |
Male |
Female |
Combined |
||
Control |
0/5 |
0/5 |
0/10 |
|
0/5 |
0/5 |
0/10 |
5000 |
0/5 |
0/5 |
0/10 |
|
0/5 |
1/5 |
0/10 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- This acute oral study is classified as acceptable. It satisfies the guideline requirement for an acute oral study OECD 401 in the rat.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to OECD Guidelines and to GLP, but not fully reported. However as this study is used in the context of a read across, Klimisch 2 is assigned.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Approximately 24 hour prior to topical application of the test material, the hair of each control and treated animal was closely clipped.
A single dose of 2000 mg/kg of the undiluted test material was administered dermally to five male and female animals. - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: On day of dosing and day 7 and 14 following dosing.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs observed each day - Statistics:
- none, there was no mortallity
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- other: 95% CL not indicated. LD50 is greater than 2000 mg/kg bw.
- Mortality:
- Mortality did not occur in treated animals.
- Clinical signs:
- No clinical signs of toxicity were observed in treated animals.
- Body weight:
- Significant decreases in bodyweight were observed in treated males on days 2, 7 and 14.
- Gross pathology:
- Skin irritation was observed for all treated animals. Multiple pinpoint scabs were observed in 3 treated males and 1 treated female.
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Mortality did not occur at doses of 2000 mg/kg bw, therefore an LD50 was not determined.
- Executive summary:
In an acute dermal toxicity study, groups of Sprague-Dawley rats (5/sex) were given a single dermal dose of sodium 4-icosylbenzenesulfonate at 2000 mg/kg bw and observed for 14 days.
No mortality occurred in this limit test, therefore an LD50 has not been determined.
This acute study is classified as acceptable. It satisfies the guideline requirement for an acute dermal study in the rat.
Reference
Table 2: Number of animals dead [and with evident toxicity] [and time range within which mortality occurred]
Dose |
Conc. |
Mortality (# dead/total) |
Time range of deaths (hours) |
Number with evident toxicity (#/total) |
||||
Male |
Female |
Combined |
Male |
Female |
Combined |
|||
Control |
0/5 |
0/5 |
0/10 |
|
0/5 |
0/5 |
0/10 |
|
2000 |
0/5 |
0/5 |
0/10 |
|
5/5 |
5/5 |
10/10 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- This acute study is classified as acceptable. It satisfies the guideline requirement for an acute dermal study in the rat.
Additional information
An acute rat oral toxicity study conducted on sodium 4-icosylbenzenesulfonate and according to OECD 401 the LD50 was reported to be >5000 mg/kg. In an acute rat dermal toxicity study conducted on sodium 4-icosylbenzenesulfonate and according to OECD 402, the LD50 was reported to be > 2000 mg/kg. No inhalation acute study was available as exposure via this route is unlikely based on vapor pressure of the substance and the unlikely possibility of exposure to aerosols, particles, or droplets of an inhalable size.
Justification for selection of acute toxicity – oral endpoint
In an acute oral toxicity study, groups of Sprague-Dawley rats (5/sex) were given a single oral dose of sodium 4-icosylbenzenesulfonate at doses of 0 or 5000 mg/kg bw and observed for 14 days. No mortality occurred in this limit test, therefore an LD50 has not been determined.
Justification for selection of acute toxicity – inhalation endpoint
Human exposure via inhalation is unlikely based on vapor pressure of the substance and the unlikely possibility of exposure to aerosols, particles, or droplets of an inhalable size.
Justification for selection of acute toxicity – dermal endpoint
In an acute dermal toxicity study, groups of Sprague-Dawley rats (5/sex) were given a single dermal dose of sodium 4-icosylbenzenesulfonate at 2000 mg/kg bw and observed for 14 days. No mortality occurred in this limit test, therefore an LD50 has not been determined.
Justification for classification or non-classification
Acute toxicity studies on read across substances of sufficient quality and tested in accordance with standard methodology showed that the acute oral LD50 was > 5000 mg/kg in rats, and the acute dermal LD50 was >2000 mg/kg. The oral LD50 cutoff value for classification is 2000 mg/kg, and the dermal LD50 cutoff value is 2000 mg/kg. Therefore, no classification is required for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.